Dose-Dependent Effects of Aloin on the Intestinal Bacterial Community Structure, Short Chain Fatty Acids Metabolism and Intestinal Epithelial Cell Permeability
Open Access
- 26 March 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 474
Abstract
Aloe leaf or purified aloin products possess numerous therapeutic and pharmaceutical properties. It is widely used as ingredients in a variety of food, cosmetic and pharmaceutical products. Animal studies have shown that consumption of aloe or purified aloin cause intestinal goblet cell hyperplasia, and malignancy. Here, we tested antibacterial effects of aloin, against intestinal commensal microbiota. Minimum inhibitory concentration of aloin for several human commensal bacterial species (Gram-positive and Gram-negative) ranged from 1 to 4 mg/ml. Metabolism studies indicated that Enterococcus faecium was capable of degrading aloin into aloe-emodin at a slower-rate compared to Eubacterium spp. As a proof of concept, we incubated 3% rat fecal-slurry (an in vitro model to simulate human colon content) with 0.5, 1, and 2 mg/ml of aloin to test antimicrobial properties. Low aloin concentrations showed minor perturbations to intestinal bacteria, whereas high concentration increased Lactobacillus sp. counts. Aloin also decreased butyrate-production in fecal microbiota in a dose-dependent manner after 24 h exposure. The 16S rRNA sequence-data revealed that aloin decreases the abundance of butyrate-producing bacterial species. Transepithelial resistant result revealed that aloin alters the intestinal barrier-function at higher concentrations (500 μM). In conclusion, aloin exhibits antibacterial property for certain commensal bacteria and decreases butyrate-production in a dose -dependent manner. HIGHLIGHTS – Aloin exhibits antibacterial properties for certain intestinal commensal bacteria. – In rat fecal slurry (an in vitro model to simulate human colon content), longer aloin exposure (24 h) decreases the butyrate production in dose dependent manner. – The 16s rRNA sequencing data show that aloin decreased the abundance of butyrate producing bacterial species. – Rat intestinal commensal bacteria metabolized aloin into aloe-emodin. – Aloin altered the intestinal epithelial cells barrier integrity, however, the metabolic product of aloin - Aloe-emodin did not alter epithelial cells permeability.Keywords
This publication has 72 references indexed in Scilit:
- Toxicologic Assessment of a Commercial Decolorized Whole Leaf Aloe Vera Juice, Lily of the Desert Filtered Whole Leaf Juice with AloesorbJournal of Toxicology, 2013
- Microbial Regulation of Glucose Metabolism and Cell-Cycle Progression in Mammalian ColonocytesPLOS ONE, 2012
- Clear Evidence of Carcinogenic Activity by a Whole-Leaf Extract of Aloe barbadensis Miller (Aloe vera) in F344/N RatsToxicological Sciences, 2012
- Systems Biology Analysis of Gene Expression during In Vivo Mycobacterium avium paratuberculosis Enteric Colonization Reveals Role for Immune TolerancePLOS ONE, 2012
- In VitroCulture Conditions for Maintaining a Complex Population of Human Gastrointestinal Tract MicrobiotaBioMed Research International, 2011
- Aloe-induced Toxic HepatitisJournal of Korean Medical Science, 2010
- Intestinal absorption of aloin, aloe-emodin, and aloesin; A comparative study using two in vitro absorption modelsNutrition Research and Practice, 2009
- The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA SequencingPLOS Biology, 2008
- The Mucin Degrader Akkermansia muciniphila Is an Abundant Resident of the Human Intestinal TractApplied and Environmental Microbiology, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007